These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1093675)
1. Localization of neuroblastoma in vivo with tumor-specific antibodies. Terman DS; Stewart I; Tavel A; Kirch D Cancer Res; 1975 Jul; 35(7):1761-6. PubMed ID: 1093675 [TBL] [Abstract][Full Text] [Related]
2. Studies on purification of antibodies against tumor-specific antigens. Park MM Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879 [TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated suppression of tumor growth. III. Molecular assay of murine IgG1 alloantibody required to cause tumor suppression in vivo. Johnson RJ; Pasternack GR; Drysdale BE; Shin HS J Immunol; 1977 Feb; 118(2):498-504. PubMed ID: 839068 [TBL] [Abstract][Full Text] [Related]
5. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas. Wilbur SM; Marelli O; Bonavida B Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of tumor antigens and clinical applications of monoclonal antibody (A 2 B 5) for neuroblastoma]. Etoh T Gan No Rinsho; 1985 Mar; 31(3):299-302. PubMed ID: 3889400 [TBL] [Abstract][Full Text] [Related]
7. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
8. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells. Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004 [TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade. Hines DL Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516 [TBL] [Abstract][Full Text] [Related]
11. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010 [TBL] [Abstract][Full Text] [Related]
12. Defining the heterogeneity of anti-tumor antibody responses. Segal GP; Klinman NR J Immunol; 1976 Jun; 116(6):1539-46. PubMed ID: 58038 [TBL] [Abstract][Full Text] [Related]
13. Modification of growth of neuroblastoma cells in syngeneic mice by aldehyde-treated neuroblastoma cells. Bertolini L; Diamond L; Revoltella R Cancer Res; 1976 Jun; 36(6):2111-2. PubMed ID: 1268864 [TBL] [Abstract][Full Text] [Related]
14. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants. Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458 [TBL] [Abstract][Full Text] [Related]
15. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas. Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354 [TBL] [Abstract][Full Text] [Related]
16. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo. Rabbani SA; Gladu J Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102 [TBL] [Abstract][Full Text] [Related]
17. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831 [TBL] [Abstract][Full Text] [Related]
18. Carbodiimide enhancement of complement-dependent antibody-mediated tumor cell lysis in vitro and antitumor activity in vivo. Fawwaz RA; Tenforde TS; Mehlberg WH Cancer Res; 1975 Mar; 35(3):679-86. PubMed ID: 1116128 [TBL] [Abstract][Full Text] [Related]
19. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide. Naito K; Pellis NR; Kahan BD Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158 [TBL] [Abstract][Full Text] [Related]
20. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen. Higgins PJ; Marucs S; Hawrylko E Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]